By contrast, Vioxx made $2.5 billion for Merck last year.
Celebrex and Vioxx have become household names in recent years.
"He did so voluntarily," the agency said.
``I was stunned,'' said Kim who had expected positive results.
``I thought the risk was going to be larger than it was,'' he said.
``This morning Merck is announcing a voluntary worldwide withdrawal of Vioxx,'' Gilmartin began.
Galson said that his agency met often with Merck to discuss earlier troubling Vioxx studies, and said that ``we insisted that we needed more information about the cardiovascular risks.''
The FDA's own study of the Vioxx safety issue has become mired in controversy.
